Cases 1 - 10 of 58
AbbVie Inc. et al v. Alembic Pharmaceuticals Limited et al
as 1:2024cv00405
Plaintiff:
AbbVie Inc., Allergan, Inc., Allergan Sales, LLC and others
Defendant:
Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In re: Entresto (Sacubitril/Valsartan)
as 23-2218
Plaintiff / Appellant:
NOVARTIS PHARMACEUTICALS CORPORATION
Defendant / Appellee:
TORRENT PHARMA INC., TORRENT PHARMACEUTICALS LTD., ALEMBIC PHARMACEUTICALS LIMITED and others
Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited
as 23-2220
Plaintiff / Appellant:
NOVARTIS PHARMACEUTICALS CORPORATION
Defendant / Appellee:
ALEMBIC PHARMACEUTICALS LIMITED and ALEMBIC PHARMACEUTICALS INC.
Acerta Pharma B.V. et al v. Alembic Pharmaceuticals Limited et al
as 1:2023cv00548
Plaintiff:
Acerta Pharma B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP and others
Defendant:
Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ACTELION PHARMACEUTICALS US, INC. et al v. ALEMBIC PHARMACEUTICALS LIMITED et al
as 2:2023cv01902
Plaintiff:
ACTELION PHARMACEUTICALS US, INC. and ACTELION PHARMACEUTICALS LTD
Defendant:
ALEMBIC PHARMACEUTICALS LIMITED and ALEMBIC PHARMACEUTICALS, INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Actelion Pharmaceuticals US, Inc. et al v. Alembic Pharmaceuticals Limited et al
as 1:2023cv00383
Plaintiff:
Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd and Nippon Shinyaku Co., Ltd.
Defendant:
Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Alcon Inc. et al v. Alembic Pharmaceuticals Ltd. et al
as 1:2023cv00194
Plaintiff:
Alcon Inc. and Alcon Laboratories, Inc.
Defendant:
Alembic Pharmaceuticals Ltd. and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Actelion Pharmaceuticals US, Inc. et al v. Alembic Pharmaceuticals Limited et al
as 1:2022cv01450
Plaintiff:
Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd and Nippon Shinyaku Co., Ltd.
Defendant:
Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited et al
as 1:2022cv01395
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Alembic Pharmaceuticals Limited, Alembic Global Holding SA, Alembic Pharmaceuticals, Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ADVERIO PHARMA GMBH et al v. ALEMBIC PHARMACEUTICAL LIMITED et al
as 2:2022cv06104
Plaintiff:
ADVERIO PHARMA GMBH, BAYER AG and BAYER HEALTHCARE PHARMACEUTICALS INC.
Defendant:
ALEMBIC PHARMACEUTICALS LIMITED, ALEMBIC GLOBAL HOLDINGS SA, ALEMBIC PHARMACEUTICALS, INC. and others
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
